rs11574703

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBS1BS2

The NM_001001548.3(CD36):​c.281+892T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0106 in 152,304 control chromosomes in the GnomAD database, including 19 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.011 ( 19 hom., cov: 32)

Consequence

CD36
NM_001001548.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.234

Publications

4 publications found
Variant links:
Genes affected
CD36 (HGNC:1663): (CD36 molecule (CD36 blood group)) The protein encoded by this gene is the fourth major glycoprotein of the platelet surface and serves as a receptor for thrombospondin in platelets and various cell lines. Since thrombospondins are widely distributed proteins involved in a variety of adhesive processes, this protein may have important functions as a cell adhesion molecule. It binds to collagen, thrombospondin, anionic phospholipids and oxidized LDL. It directly mediates cytoadherence of Plasmodium falciparum parasitized erythrocytes and it binds long chain fatty acids and may function in the transport and/or as a regulator of fatty acid transport. Mutations in this gene cause platelet glycoprotein deficiency. Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Feb 2014]
CD36 Gene-Disease associations (from GenCC):
  • platelet-type bleeding disorder 10
    Inheritance: AR Classification: STRONG Submitted by: Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0106 (1618/152304) while in subpopulation NFE AF = 0.0164 (1116/68022). AF 95% confidence interval is 0.0156. There are 19 homozygotes in GnomAd4. There are 816 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 19 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001001548.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CD36
NM_001001548.3
MANE Select
c.281+892T>C
intron
N/ANP_001001548.1P16671-1
CD36
NM_000072.3
c.281+892T>C
intron
N/ANP_000063.2A4D1B1
CD36
NM_001001547.3
c.281+892T>C
intron
N/ANP_001001547.1P16671-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CD36
ENST00000447544.7
TSL:5 MANE Select
c.281+892T>C
intron
N/AENSP00000415743.2P16671-1
CD36
ENST00000309881.11
TSL:1
c.281+892T>C
intron
N/AENSP00000308165.7P16671-1
CD36
ENST00000394788.7
TSL:1
c.281+892T>C
intron
N/AENSP00000378268.3P16671-1

Frequencies

GnomAD3 genomes
AF:
0.0106
AC:
1618
AN:
152186
Hom.:
19
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00890
Gnomad ASJ
AF:
0.00230
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00600
Gnomad FIN
AF:
0.0201
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0164
Gnomad OTH
AF:
0.00669
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0106
AC:
1618
AN:
152304
Hom.:
19
Cov.:
32
AF XY:
0.0110
AC XY:
816
AN XY:
74480
show subpopulations
African (AFR)
AF:
0.00241
AC:
100
AN:
41560
American (AMR)
AF:
0.00889
AC:
136
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00230
AC:
8
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5176
South Asian (SAS)
AF:
0.00600
AC:
29
AN:
4832
European-Finnish (FIN)
AF:
0.0201
AC:
214
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0164
AC:
1116
AN:
68022
Other (OTH)
AF:
0.00662
AC:
14
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
83
165
248
330
413
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0100
Hom.:
4
Bravo
AF:
0.00958
Asia WGS
AF:
0.00115
AC:
4
AN:
3476

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
3.9
DANN
Benign
0.81
PhyloP100
-0.23
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11574703; hg19: chr7-80286908; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.